Articles On Global Health (ASX:GLH)
Title | Source | Codes | Date |
---|---|---|---|
Closing Bell: Local markets and key commodities slump together on Monday
ASX 200 ends 0.5pc lower after a difficult start to the week Energy Sector the worst of some poor to middling performances Small caps led by AuMake on news of a new deal in China Last week’s record highs seem a distant memory for the... |
Stockhead | GLH | 4 days ago |
CLOSING BELL: Big effort but little reward as miners, tech drag the ASX up 0.28pc
Materials, Energy and Infotech dominate a sluggish day on Wednesday Booktopia collapses with a grim outlook for a final chapter ahead Some standout performances among the small caps, but who won? The ASX 200 benchmark struggled to make... |
Stockhead | GLH | 3 weeks ago |
ASX Health Stocks: Island to tackle deadly Ebola virus
Island Pharmaceuticals inks deal to develop a treatment for potentially deadly viruses like Ebola Amplia recruits key 26th patient in Phase 2a trial of new treatment for advanced pancreatic cancer Melodiol Global Health records unaudited... |
Stockhead | GLH | 3 weeks ago |
ASX Health June Winners: Actinogen and Optiscan led a sector in good shape
The ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biotechs in June were Actinogen, Optiscan and EZZ Life Science, amongst others The S&P/ASX 200 Health Care index [XHJ] saw a 4% increase... |
Stockhead | GLH | 3 weeks ago |
ASX June Winners: The best 50 stocks as inflation spikes
S&P/ASX 200 rose 1% in June with large caps leading gains with mid, small and emerging companies lagging S&P/ASX 200 financials and consumer staples were the top performers in June with materials the biggest laggard Urea fertiliser... |
Stockhead | GLH | 3 weeks ago |
CLOSING BELL: ASX showing signs of a hangover on bumpy New Financial Year day
Choppy day leaves the ASX 200 benchmark below zero, down -0.2pc Energy surges on news of a coal fire in Queensland, because that’s good for business everywhere else Small Caps winners’ list dominated by a $12 million boat sale by Wellard,... |
Stockhead | GLH | 3 weeks ago |
Top 10 at 10: High tech wheelchairs, copper discoveries, and a big uranium bounty
Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | GLH | 1 month ago |
Property valued at up to $12m as Melodiol secures convertible note deal
Two independent appraisals value land and building owned by Melodiol’s Canadian subsidiary Mernova at between $10.4 – $12 million Appraisals follow strong revenue progress at Melodiol, with $21.6m in revenue delivered for FY23 ME1 inks de... |
Stockhead | GLH | 1 month ago |
ASX Health Winners in May: LTR Pharma leads, and why hopes are high for biotech stocks this year
S&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biotech stocks We take a look at the ASX biotech winners for the month The S&P/ASX 200 Health Care [XHJ] closed flattish for the month o... |
Stockhead | GLH | 1 month ago |
Top 10 at 10: lithium drilling and a breast cancer breakthrough
Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | GLH | 1 month ago |
Top 10 at 10: Falcon’s Farrelly find has the punters pumped
Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | GLH | 1 month ago |
Top 10 at 10: Which tiny explorer caught the eye of one of Australia’s biggest gold companies?
Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | GLH | 1 month ago |
‘Stable, material revenue generating business:’ Melodiol’s Canadian subsidiary maintains strong progress
Mernova finalises additional product development activities across edibles, vapes and dabbers Agreements made with contract growers to supplement existing cannabis capacity given strong demand Q2 FY24 purchase orders of $1.56m to date, hi... |
Stockhead | GLH | 1 month ago |
Top 10 at 10: Banana recycler slides into big contract win
Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | GLH | 1 month ago |
Check Up: Alzheimer’s is ‘preventable’, so here’s what you must do; and recent ASX biotech winners
Research shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase the risk of dementia We look at the best performing ASX stocks over the past month The phrase ‘you are what you eat’ was coined almost a c... |
Stockhead | GLH | 2 months ago |
Closing Bell: ASX fleeced as retail stocks plunge; Alliance Nickel soars on great big grant
ASX losses accelerate after sluggish retail sector updates Baby Bunting, Temple & Webster, JB Hi-fi all under pressure on soft sales Alliance Nickel soars on fat federal grant After opening modestly higher this morning, the ASX qui... |
Stockhead | GLH | 2 months ago |
Melodiol’s Mernova thriving in Canada with solid start to quarter, expanded product reach
Melodiol’s Canadian subsidiary Mernova continues to make strong progress Mernova launching additional products across various Canadian provinces Mernova has received purchase orders of $1.3 million in strong start to Q2 FY24 Special Re... |
Stockhead | GLH | 2 months ago |
ASX Health Stocks: Neuren’s Q1 DAYBUE sales disappoint; 4DX gets another Medicare reimbursement in US
Neuren Pharma’s Q1 DAYBUE sales disappoint 4DMedical’s CT LVAS technology gets reimbursement in US Melodiol’s Canadian subsidiary, Mernova, continues to make strong progress Neuren’s Q1 disappoints Neuren Pharma (ASX:NEU) slumped by ove... |
Stockhead | GLH | 2 months ago |
Market Highlights: Shopify, Airbnb drag down Wall Street; and what’s been moving the gold price lately?
ASX to dip slightly at the open after a modest run on Wall Street Shopify, Airbnb and Uber took a dive overnight after earnings release What’s been moving the gold price? Aussie shares are poised to open modestly lower on Thursday,... |
Stockhead | GLH | 2 months ago |
Top 10 at 11: Who is getting decent results in this morning?
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the... |
Stockhead | GLH | 2 months ago |
Top 10 at 10: ‘Outstanding’ lithium hits and a $30m ADF cash splash
Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | GLH | 2 months ago |
Top 10 at 10: Krakatoa fires up again while Pivotal hits thick copper
Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | GLH | 2 months ago |
ASX Health Winners April: Mesoblast leads; and why the Health sector is just built different
ASX Health sector was in correction territory in April Why is the health sector different from other sectors? We look at the best performing ASX health stocks for the month The S&P/ASX 200 Health Care [XHJ] had a soft month in April... |
Stockhead | GLH | 2 months ago |
Melodiol delivers strong revenues in Q1 as US moves to reclassify cannabis
Melodiol Global Health Q1 FY24 unaudited revenue of $4.4m marks a 91% increase on pcp Company remains focused on reducing operating costs, while pursuing high growth revenue opportunities US Drug Enforcement Administration to reclassify ca... |
Stockhead | GLH | 2 months ago |
Check Up: Big breakthrough in acne treatment, and recent ASX biotech winners
There’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to control sebum production We look at the best and worst performing ASX health stocks in the past month Scientists have made a significant b... |
Stockhead | GLH | 3 months ago |
Weed Week: A VAST majority of Americans now want marijuana to be legal
Where are we in terms of US legalisation of cannabis? What about the current legal landscape for cannabis in Australia? We look at the best performing ASX weed stocks this past month Global weed stocks have been on bumpy ride over the p... |
Stockhead | GLH | 3 months ago |
Melodiol welcomes Chuck’s petition to pass US SAFER Banking Act
US Majority Leader Chuck Schumer is urging people to endorse SAFER Banking Act by signing petition Act aims to enhance access to traditional financial services for cannabis companies in the US Melodiol Global Health could benefit as one of... |
Stockhead | GLH | 3 months ago |
Melodiol’s Mernova gains more traction in Canada: revenues increase, new products launched
Special Report: Melodiol Global’s subsidiary Mernova continues to gain traction in Canada as the company launches new cannabis products across various markets. Melodiol Global Health Limited (ASX:ME1)’s wholly-owned Canadian subsidiary, Mer... |
Stockhead | GLH | 3 months ago |
Top 10 at 11: High grade silica lights a small caps fire as miners make moves this morning
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the... |
Stockhead | GLH | 3 months ago |
Closing Bell: ASX rebounds as soft CPI bolsters August rate cut hopes; OSX and TLM lead today’s winners
The ASX 200 erases early morning’s losses, rallying to close the day +0.3% higher. This comes as the ABS released its monthly CPI report, which shows that YoY inflation was steady in February at 3.4% for a third straight month. The figure... |
Stockhead | GLH | 3 months ago |
Melodiol subsidiaries contribute $3.1 million revenue in first two months of 2024
Melodiol Global Health reports total unaudited revenue of $3.1 million in first two months of FY24 Recreational cannabis subsidiary Mernova Medicinal contributes $1.45 million driven by Ritual branded products ME1 recently reported total... |
Stockhead | GLH | 4 months ago |
Top 10 at 11: Little diggers turn up value as lithium, gold finds continue
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the... |
Stockhead | GLH | 4 months ago |
New PeerLINC Knowledge Hub will Leverage Local Expertise and Experience to Accelerate New, More Effective TB Cures Around the World
Hub will focus on supporting global use of new treatments that effectively treated drug-resistant TB in 98% of Filipino participants MANILA, Australia, March 25, 2024 /PRNewswire/ — TB Alliance’s new Peer-to-Peer Learning for Innovative Cu... |
FNArena | GLH | 4 months ago |
Australian Government Grants TB Alliance an Award to Help Bolster Clinical Research and Improve Access to New Treatments for Drug-Resistant TB
AUD 17 Million Grant over 5 Years Will Fund Next-Generation TB Cures CANBERRA, Australia, March 25, 2024 /PRNewswire/ — The Australian Government, through the Partnerships for a Healthy Region initiative, has announced a new AUD 17 million... |
FNArena | GLH | 4 months ago |
ASX February winners: The best 50 stocks as a ‘super-heroic small cap’ soars 322%
S&P/ASX 200 rose 0.8% in February with Large Cap S&P/ASX 50 underperforming Midcap and Small Ordinaries Tech sector was the big winner up 19% in February as energy and materials sector slumped Nyrada soars after preclinical study... |
Stockhead | GLH | 4 months ago |
Check Up: Big week in world of biotech after these 2 Nasdaq stocks announce breakthroughs
Viking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on pancreatic cancer results We look at the recent best performing ASX health stocks There were a couple of big news from the world of biotec... |
Stockhead | GLH | 4 months ago |
Recce Pharmaceuticals leads the way in collaborative Anti-Infective research
Recce Pharmaceuticals (ASX:RCE) highlights ongoing initiatives within its Anti-Infective Research (AIR) Unit situated at the Murdoch Children’s Research Institute (MCRI), Victoria The collaboration has been crucial in delivering positive... |
themarketonline.com.au | GLH | 5 months ago |
Closing Bell: Commodity prices, resurgent rate fears drag ASX to third straight loss
ASX200 drops about 0.7pc on Wednesday Consumer Staples craters, as WOW CEO departs Small Caps led by diggers IXR, AW1 and the biopharma Alterity The ASX200 has ended lower on Wednesday, tracking losses in New York as traders brace – a... |
Stockhead | GLH | 5 months ago |
Closing Bell: Local markets ride commodities higher after a blow to US confidence on Friday
Local markets ride commodities lift to offset weak performance from Wall Street on Friday ASX 200 benchmark finished the day on +0.09pc, a lot higher than it really had any right to Resources led the way, overcoming a significant deadwei... |
Stockhead | GLH | 5 months ago |
Melodiol subsidiary Mernova expands products in six lucrative Canadian provinces
Melodiol subsidiary Mernova Medicinal continues to grow as a dominant player in lucrative Canadian cannabis market Product range expands into six Canadian provinces Further cost optimisation initiatives to remove $400k from Mernova annua... |
Stockhead | GLH | 5 months ago |
Closing Bell: Blood plasma giant CSL bleeds out in front of entire ASX on Monday
ASX200 dragged down by bad drugs The IT Sector is up 1.1pc, Healthcare is down about 3.2pc Small cap winners led by American Rare Earths and Appen The benchmark was shot through the heart by CSL this morning leaving everything else in... |
Stockhead | GLH | 5 months ago |
Melodiol enjoys milestone 2023 as subsidiaries bank profits
Melodiol Global Health says 2023 been a milestone year with strong growth across portfolio Melodiol delivering on strategy to bring core operating subsidiaries into profitability Company says its strategic priority continues to be gener... |
Stockhead | GLH | 7 months ago |
10 at 11ish: Aurumin to sell iron rights to Mineral Resources
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the trading day by... |
Stockhead | GLH | 8 months ago |
Top 10 at 11: Major gains for sustainable ag after Roots flies a shipment out of Israel
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the trading day by... |
Stockhead | GLH | 8 months ago |
Check Up: Biden-Xi meeting could finally end opioids crisis in the US; and recent ASX biotech winners
Xi and Biden set to agree on restricting fentanyl Fentanyl is a synthetic opioid responsible for the opioids epidemic in the US We look at the best performing health stocks over the past couple of weeks China’s President Xi is expected... |
Stockhead | GLH | 8 months ago |
In Case You Missed It: Firebrick back after review points to ‘inaccuracies in trial efficacy data’
Stockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might have slipped beneath your radar. Below is a wrap of the top 20 performing stocks, by percentage, that made announcements today. ICYMI Leaderb... |
Stockhead | GLH | 8 months ago |
Melodiol subsidiary HHI Australia delivers $1 million revenue in October
Melodiol subsidiary Health House International Australia delivers ~$1 million in revenue for October Strong October performance continues progress from Q3 revenue of ~$3 million 12 month sales are ~$14 million, with EBITDA margin 12.7%... |
Stockhead | GLH | 8 months ago |
In Case You Missed It: Record monthly Canadian cannabis revenue takes top spot
Stockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might have slipped beneath your radar. Below is a wrap of the top 20 performing stocks, by percentage, that made announcements today. ICYMI Leade... |
Stockhead | GLH | 8 months ago |
10 at 11ish: First Au gets nod for bulk sampling at Victorian gold project
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the trading day by... |
Stockhead | GLH | 8 months ago |
‘Current inventory moving very quickly’: Melodiol’s Canadian subsidiary continues to deliver record revenue
Mernova Medicinal has achieved its highest ever monthly revenue of nearly $900k in October Company has already received more than $600k of product orders for November providing a bumper start to the quarter ME1 reports ~$7.5 million in u... |
Stockhead | GLH | 8 months ago |